logo

Last Update

This profile was last updated on 6/10/2015 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong A.P. Pharma?

A.P. Pharma

Chief Commercial Officer

A.P. Pharma Inc

HQ Phone:  (650) 366-2626

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

A.P. Pharma Inc

123 Saginaw Drive

Redwood City, California,94063

United States

Company Description

About A.P. Pharma: A.P. Pharma is a specialty pharmaceutical company developing products using its proprietary Biochronomer™ polymer-based drug delivery technology. The Company's primary focus is on its lead product candidate, APF530, for the prevention of CIN...more

Background Information

Employment History

Chief Commercial Officer

SmithOnStocks


President

PreScience Labs LLC


Vice President Clinical Development, Actelion Pharmaceuticals, Senior Vice President Medical

J. Robert Scott


Corporate Controller of The Cooper Companies, Vice President, Finance and Administration

CooperVision Inc


Affiliations

Heron Therapeutics, Inc.

Board Member


CCBN.com Inc

Board Member


Prescription Drug User Fee Act

Founder


Web References(200 Total References)


US PATENT APPLICATIONS IN PHARMACEUTICAL EXCIPIENTS IN 2012

www.formulascan.com [cached]

Applicant/Assignee: A.P. PHARMA, INC, A.P. PHARMA
Application No.: 13/279938 Filing Date: 24/Oct/2011


Heron Therapeutics • Investor Relations • News Release

phx.corporate-ir.net [cached]

A.P. Pharma Announces Study Finding Continuous Exposure to a 5-HT3 Antagonist Using APF530 Provides Better Emetic Control
Heron Therapeutics • Investor Relations • News Release Heron Therapeutics A.P. Pharma Announces Study Finding Continuous Exposure to a 5-HT3 Antagonist Using APF530 Provides Better Emetic Control A.P. Pharma's A.P. Pharma A.P. Pharma is a specialty pharmaceutical company developing products using its proprietary Biochronomer™ polymer-based drug delivery technology. The Company's primary focus is on its lead product, APF530, for the prevention of CINV. A.P. Pharma


Heron Therapeutics • Board of Directors

www.appharma.com [cached]

Stephen R. Davis joined A.P. Pharma as Executive Vice President and Chief Operating Officer in May 2013 and has served as a member of our board of directors since June 2012.
Barry D. Quart, Pharm.D. joined A.P. Pharma in May 2013 as Chief Executive Officer and has served as a member of our board of directors since June 2012. Robert Rosen joined A.P. Pharma as Senior Vice President and Chief Commercial Officer in October 2012 and was appointed to President in May 2013. Prior to joining A.P, Pharma, he served as global head of oncology at Bayer HealthCare, where he was responsible for the development of the global oncology business unit for regions that included the Americas, Europe, Japan, and Asia Pacific from 2005 to 2011. During his tenure at Bayer Healthcare, he led the launch of Nexavar for the treatment of renal cell carcinoma and hepatocellular carcinoma. Nexavar's worldwide sales in 2011 were $1.0 billion. He also led premarket activities for Stivarga for gastrointestinal stromal tumors and colon cancer and alpharadin for prostate cancer.


Heron Therapeutics • Investor Relations • News Release

phx.corporate-ir.net [cached]

A.P. Pharma Announces First Quarter 2013 Financial Results and Highlights Recent Corporate Progress
Heron Therapeutics • Investor Relations • News Release Heron Therapeutics A.P. Pharma Announces First Quarter 2013 Financial Results and Highlights Recent Corporate Progress A.P. Pharma A.P. Pharma's A.P. Pharma A.P. Pharma


Heron Therapeutics • Investor Relations • News Release

phx.corporate-ir.net [cached]

A.P. Pharma Appoints New Management Team
Heron Therapeutics • Investor Relations • News Release Heron Therapeutics A.P. Pharma Appoints New Management Team A.P. Pharma Each executive joined A.P. Pharma's A.P. Pharma A.P. Pharma A.P. Pharma A.P. Pharma's A.P. Pharma A.P. Pharma


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory